Back to Search
PAUL LAVIGNE, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1992935076IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
240678(MA)
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
0101262694(VA)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
0101262694(VA)
CMS Specialties
PrimaryINTERVENTIONAL CARDIOLOGY
Additional
CARDIOVASCULAR DISEASE (CARDIOLOGY)INTERNAL MEDICINE
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 2009
Research & Publications (20)
Validation of the mechanism of cholesterol binding by StAR using short molecular dynamics simulations.
PMID 19095060·J Steroid Biochem Mol Biol·2009
8-other
Temperature-induced ligand contact point variations of the hAT1 receptor and of the constitutively active mutant N111G-hAT1.
PMID 19400218·Adv Exp Med Biol·2009
8-other
The self-association of two N-terminal interaction domains plays an important role in the tetramerization of TRPC4.
PMID 19070363·Cell Calcium·2009
7-preclinical
Identification of transmembrane domain 6 & 7 residues that contribute to the binding pocket of the urotensin II receptor.
PMID 19426676·Biochem Pharmacol·2009
7-preclinical
The mechanism of specific binding of free cholesterol by the steroidogenic acute regulatory protein: evidence for a role of the C-terminal alpha-helix in the gating of the binding site.
PMID 18729825·Biosci Rep·2009
8-other
The second transmembrane domain of the human type 1 angiotensin II receptor participates in the formation of the ligand binding pocket and undergoes integral pivoting movement during the process of receptor activation.
PMID 19276075·J Biol Chem·2009
7-preclinical
Pluronic F-127 as a cell carrier for bone tissue engineering.
PMID 18987015·J Biomater Appl·2009
7-preclinical
Activation induces structural changes in the liganded angiotensin II type 1 receptor.
PMID 19635801·J Biol Chem·2009
7-preclinical
Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site.
PMID 19631193·Biochem Pharmacol·2009
8-other
Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis.
PMID 18500247·Mol Ther·2008
7-preclinical
4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase.
PMID 18782442·Arthritis Res Ther·2008
8-other
An active role for soluble and membrane intercellular adhesion molecule-1 in osteoclast activity in vitro.
PMID 18979153·J Bone Miner Metab·2008
8-other
Cholesterol binding is a prerequisite for the activity of the steroidogenic acute regulatory protein (StAR).
PMID 18341481·Biochem J·2008
8-other
Elucidation of the structural determinants responsible for the specific formation of heterodimeric Mxd1/Max b-HLH-LZ and its binding to E-box sequences.
PMID 18155722·J Mol Biol·2008
8-other
Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease.
PMID 18263585·J Biol Chem·2008
8-other
Characterization of novel isoforms and evaluation of SNF2L/SMARCA1 as a candidate gene for X-linked mental retardation in 12 families linked to Xq25-26.
PMID 18302774·BMC Med Genet·2008
8-other
Biological properties and functional determinants of the urotensin II receptor.
PMID 18155322·Peptides·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 800 WASHINGTON ST
BOSTON, MA 02111 - Phone
- (617) 636-5000
Quick Facts
- NPI
- 1992935076
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile